2d Qsar and Docking Studies on Chalcone - Quinoxaline Variants – a Potential Target for Acetylcholinestrase Inhibitors
Preprint in Research Square (May 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Real-world Utilisation of the Rivastigmine Transdermal Patches Accompanying the Use of Risk Minimisation Tools in Patients with Dementia
Article in Current Alzheimer Research (January 2021)
Evaluation of rivastigmine in Alzheimer's disease
Article in Neurodegenerative Disease Management (November 2020)